Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome

Table 1 Clinical data of 21 patients with pulmonary pathology selected from 525 subjects with suspicion of paraneoplastic neurological syndromes.

Patient	Age	Gender	Antibody	NPS	Pulmonary disease
J.F.	56	Male	Negative	Motor neuron disease	Small-cell lung cancer
J.W.	52	Male	Anti-Ri, anti-Yo	Neuropathy	Chronic obstructive pulmonary disease
B.K.	54	Female	Negative	Neuropathy	Non-small-cell lung cancer, brain metastases
K.K.	55	Female	Negative	Neuropathy	Non-small-cell lung cancer
S.P.	75	Male	Anti-Hu	Limbic encephalitis	Small-cell lung cancer
E.S.	42	Female	Negative	Pyramidal syndrome	Non-small-cell lung cancer
A.S.	41	Male	Negative	Pyramidal syndrome	Pulmonary sarcoidosis
S.K.	31	Female	Anti-myelin	Cerebellar syndrome	Bronchial asthma
W.J.	57	Female	Anti-MAG	Neuropathy	Bronchial asthma
A.S.	51	Female	Negative	Polymyositis	Non-small-cell lung cancer, ovarian cancer
K.G.	58	Female	Anti-MAG	Neuropathy	Small-cell lung cancer
H.R.	47	Female	Anti-Hu	Pyramidal syndrome	Small-cell lung cancer
K.L.	60	Female	Anti-Ri	Neuropathy	Breast cancer, pulmonary metastases
I.N.	53	Female	Negative	Brachial plexopathy	Pulmonary metastases
T.Z.	70	Female	Negative	Myopathy	Chronic obstructive pulmonary disease
A.S.	41	Male	Negative	Pyramidal syndrome	Pulmonary sarcoidosis
W.J.	57	Female	Anti-MAG	Neuropathy	Bronchial asthma
I.B.	38	Female	Anti-MAG	Myasthenia gravis	Bronchial asthma
F.C.	68	Male	Anti-MAG	Neuropathy	Small-cell lung cancer
A.K.	52	Female	Negative	Neuropathy	Small-cell lung cancer, brain metastases
A.B.	69	Female	Anti-amphiphysin	Limbic encephalitis, paraneoplastic cerebellar degeneration.	Non-small-cell lung cancer

ISSN: 2047-783X